Jingjing Liu
Affiliations: | 2013-2014 | Ophthalmic Research | Cleveland Clinic Foundation, Cleveland, OH, United States |
Area:
Experimental Eye ResearchGoogle:
"Jingjing Liu"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Jingjing Liu | research assistant | 2013-2014 | Cleveland Clinic Foundation |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhou G, Zhang W, Wen H, et al. (2023) Esculetin improves murine mastitis induced by streptococcus isolated from bovine mammary glands by inhibiting NF-κB and MAPK signaling pathways. Microbial Pathogenesis. 185: 106393 |
| Liu J, Zhang Q, Wang J, et al. (2023) Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer. International Journal of Molecular Sciences. 24 |
| Pu X, Xu C, Wang Q, et al. (2023) Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China. Thoracic Cancer |
| Wu Z, Qu B, Yuan M, et al. (2023) CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2303246 |
| Fan G, Li D, Liu J, et al. (2023) HNRNPD is a prognostic biomarker in non-small cell lung cancer and affects tumor growth and metastasis via the PI3K-AKT pathway. Biotechnology & Genetic Engineering Reviews. 1-20 |
| Liu J, Jing W, Wang T, et al. (2022) Functional metabolomics revealed the dual-activation of cAMP-AMP axis is a novel therapeutic target of pancreatic cancer. Pharmacological Research. 106554 |
| Roussel MF, Jonchere B, Williams J, et al. (2022) Combination of ribociclib with BET-bromodomain and PI3K/mTOR inhibitors for medulloblastoma treatment in vitro and in vivo. Molecular Cancer Therapeutics |
| Pribnow A, Jonchere B, Liu J, et al. (2022) Combination of ribociclib and gemcitabine for the treatment of medulloblastoma. Molecular Cancer Therapeutics |
| Zhao F, Li S, Liu J, et al. (2022) Long non-coding RNA TRIM52-AS1 sponges microRNA-577 to facilitate diffuse large B cell lymphoma progression via increasing TRIM52 expression. Human Cell |
| Liu J, You M, Yao Y, et al. (2021) SRSF1 plays a critical role in invariant natural killer T cell development and function. Cellular & Molecular Immunology |